{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T05:54:22Z","timestamp":1693115662264},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","funder":[{"name":"Sandoz International GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s12325-016-0301-1","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T06:42:02Z","timestamp":1455691322000},"page":"423-434","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age"],"prefix":"10.1007","volume":"33","author":[{"given":"Hans-Peter","family":"Schwarz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mieczys\u0142aw","family":"Walczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Birkholz-Walerzak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mieczyslaw","family":"Szalecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Nanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Woehling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Schuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,17]]},"reference":[{"key":"301_CR1","unstructured":"Omnitrope\u00ae European Public Assessment Report 2008. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Scientific_Discussion\/human\/000607\/WC500043692.pdf . Accessed Feb 12, 2016."},{"key":"301_CR2","unstructured":"Omnitrope\u00ae summary of product characteristics 2008. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000607\/WC500043695.pdf . Accessed Feb 12, 2016."},{"key":"301_CR3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/er.2006-0039","volume":"28","author":"P Saenger","year":"2007","unstructured":"Saenger P, Czernichow P, Hughes I, Reiter EO. Small for gestational age: short stature and beyond. Endocr Rev. 2007;28:219\u201351.","journal-title":"Endocr Rev"},{"key":"301_CR4","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1210\/jc.2006-2017","volume":"92","author":"PE Clayton","year":"2007","unstructured":"Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, Rogol A. Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J Clin Endocrinol Metab. 2007;92:804\u201310.","journal-title":"J Clin Endocrinol Metab"},{"key":"301_CR5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000053244","volume":"54","author":"MC Boguszewski","year":"2000","unstructured":"Boguszewski MC, de Zegher F, Albertsson-Wikland K. Serum leptin in short children born small for gestational age: dose-dependent effect of growth hormone treatment. Horm Res. 2000;54:120\u20135.","journal-title":"Horm Res"},{"key":"301_CR6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/bmj.301.6746.259","volume":"301","author":"DJ Barker","year":"1990","unstructured":"Barker DJ, Bull AR, Osmond C, Simmonds SJ. Fetal and placental size and risk of hypertension in adult life. BMJ. 1990;301:259\u201362.","journal-title":"BMJ"},{"key":"301_CR7","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/0140-6736(93)91224-A","volume":"341","author":"DJ Barker","year":"1993","unstructured":"Barker DJ, Gluckman PD, Godfrey KM, et al. Fetal nutrition and cardiovascular disease in adult life. Lancet. 1993;341:938\u201341.","journal-title":"Lancet"},{"key":"301_CR8","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJMoa035698","volume":"350","author":"SK Bhargava","year":"2004","unstructured":"Bhargava SK, Sachdev HS, Fall CH, et al. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med. 2004;350:865\u201375.","journal-title":"N Engl J Med"},{"key":"301_CR9","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1007\/s00125-006-0459-1","volume":"49","author":"JG Eriksson","year":"2006","unstructured":"Eriksson JG, Osmond C, Kajantie E, Fors\u00e9n TJ, Barker DJ. Patterns of growth among children who later develop type 2 diabetes or its risk factors. Diabetologia. 2006;49:2853\u20138.","journal-title":"Diabetologia"},{"key":"301_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13554-014-0014-4","volume":"4","author":"HP Schwarz","year":"2014","unstructured":"Schwarz HP, Birkholz-Walerzak D, Szalecki M, et al. One-year data from a long-term phase IV study of recombinant human growth hormone in short children born small for gestational age. Biol Ther. 2014;4:1\u201313.","journal-title":"Biol Ther."},{"key":"301_CR11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2431-8-8","volume":"8","author":"A Niklasson","year":"2008","unstructured":"Niklasson A, Albertsson-Wikland K. Continuous growth reference from 24th week of gestation to 24\u00a0months by gender. BMC Pediatr. 2008;8:8.","journal-title":"BMC Pediatr."},{"key":"301_CR12","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1515\/CCLM.2004.112","volume":"42","author":"MW Elmlinger","year":"2004","unstructured":"Elmlinger MW, K\u00fchnel W, Weber MM, Ranke MB. Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor (IGF-I) and IGF binding protein-3 (IGFBP-3). Clin Chem Lab Med. 2004;42:654\u201364.","journal-title":"Clin Chem Lab Med"},{"key":"301_CR13","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s12325-008-0101-3","volume":"25","author":"H Jung","year":"2008","unstructured":"Jung H, Rosilio M, Blum WF, Drop SL. Growth hormone treatment for short stature in children born small for gestational age. Adv Ther. 2008;25:951\u201378.","journal-title":"Adv Ther."},{"issue":"Suppl 3","key":"301_CR14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000091719","volume":"65","author":"WS Cutfield","year":"2006","unstructured":"Cutfield WS, Lindberg A, Rapaport R, Wajnrajch MP, Saenger P. Safety of growth hormone treatment in children born small for gestational age: the US trial and KIGS analysis. Horm Res. 2006;65(Suppl 3):153\u20139.","journal-title":"Horm Res"},{"key":"301_CR15","first-page":"113","volume":"142","author":"J Lebl","year":"2011","unstructured":"Lebl J, Lebenthal Y, Kolouskova S, et al. Metabolic impact of growth hormone treatment in short children born small for gestational age. Horm Res Paediatr. 2011;142:113\u20136.","journal-title":"Horm Res Paediatr."},{"key":"301_CR16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1067\/mpd.2003.8","volume":"142","author":"WS Cutfield","year":"2003","unstructured":"Cutfield WS, Jackson WE, Jefferies C, et al. Reduced insulin sensitivity during growth hormone therapy for short children born small for gestational age. J Pediatr. 2003;142:113\u20136.","journal-title":"J Pediatr"},{"key":"301_CR17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000358196","volume":"81","author":"AM Kappelgaard","year":"2014","unstructured":"Kappelgaard AM, Kiyomi F, Horikawa R, et al. The impact of long-term growth hormone treatment on metabolic parameters in Japanese patients with short stature born small for gestational age. Horm Res Paediatr. 2014;81:272\u20139.","journal-title":"Horm Res Paediatr."},{"key":"301_CR18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000249164","volume":"72","author":"T Romer","year":"2009","unstructured":"Romer T, Saenger P, Peter F, et al. Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope\u00ae in the treatment of growth hormone deficient children: results of a phase III study. Horm Res. 2009;72:359\u201369.","journal-title":"Horm Res"},{"key":"301_CR19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s12325-011-0063-8","volume":"28","author":"J L\u00f3pez-Siguero","year":"2011","unstructured":"L\u00f3pez-Siguero J, Borr\u00e1s P\u00e9rez MV, Balser S, Khan-Boluki J. Long-term safety and efficacy of the recombinant human growth hormone Omnitrope\u00ae in the treatment of Spanish growth hormone deficient children: results of a phase III study. Adv Ther. 2011;28:879\u201393.","journal-title":"Adv Ther."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-016-0301-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T06:06:03Z","timestamp":1498284363000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-016-0301-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,17]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["301"],"URL":"https:\/\/doi.org\/10.1007\/s12325-016-0301-1","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,17]]}}}